Key Catalysts Emerge in Oncology, Synthetic Biology, and M&A Activity as Markets Open
KRAIG BIOCRAFT LABS INC (KBLB)
NASDAQ:AMEX Investor Relations:
kraiglabs.com/investors
Company Research
Source: GlobeNewswire
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Markets open this morning with a distinctly biotech-heavy narrative delivering milestone developments. Zymeworks and Jazz Drop Landmark Phase 3 Data: Ziihera Positioned as New HER2 Standard in First-Line GEA The biggest headline of the morning comes from Zymeworks (NASDAQ:ZYME), after partners Jazz Pharmaceuticals and BeOne Medicines unveiled positive top-line results from the Phase 3 HERIZON-GEA-01 study evaluating Ziihera (zanidatamab-hrii) in front-line HER2-positive gastroesophageal adenocarcinoma (GEA). Why it matters: This is the first Phase 3 trial to show superiority over the long-standing regimen trastuzumab + chemotherapy, positioning Ziihera as a potential agent-of-choice and new standard of care in a difficult cancer marked by poor global survival rates. Key readouts: Ziihera + chemotherapy delivered statistically significant, clinically meaningful PFS improvement vs. trastuzumab + chemo.OS showed a clinically meaningful eff
Show less
Read more
Impact Snapshot
Event Time:
KBLB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KBLB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KBLB alerts
High impacting KRAIG BIOCRAFT LABS INC news events
Weekly update
A roundup of the hottest topics
KBLB
News
- Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast Asia [Yahoo! Finance]Yahoo! Finance
- Kraig Biocraft Laboratories Launches Significant Hiring Initiative to Support Expanded Spider Silk Production Footprint in Southeast AsiaGlobeNewswire
- Electrify, Simplify, Spin-Off & ScaleGlobeNewswire
- 24/7 Market News- Kraig Biocraft Laboratories Receives Spider Silk Order from Global Performance Sports Brand, Marking Several Major MilestonesGlobeNewswire
- Kraig Biocraft Laboratories Fulfilling Order for Customized Spider Silk Application from Leading Performance Sports Brand [Yahoo! Finance]Yahoo! Finance
KBLB
Sec Filings
- 11/17/25 - Form 424B3
- 11/17/25 - Form 424B3
- 11/12/25 - Form 10-Q
- KBLB's page on the SEC website